Limbic and new onset refractory tonic status epilepticus (NORSE) in anti-NMDAR encephalitis

Clinical Neurophysiology Practice
P W Kaplan, John Probasco

Abstract

To present a case of anti-NMDA receptor encephalitis (anti-NMDAR) with new onset refractory non-convulsive status epilepticus (NORSE). Case report with clinical details, MRI, PET, and EEG illustrations. New onset refractory status epilepticus (NORSE) may arise from anti-NMDAR, and offers diagnostic and treatment challenges for immuno-therapy and refractory status epilepticus. Non-convulsive status epilepticus with generalized fast activity, has not been reported in anti-NMDAR, in NORSE. A patient with anti-NMDAR and generalized status with stiffening, right focal weakness, high frequency alpha/beta on EEG, brain FDG-PET/CT changes in the left temporo-parietal regions and cerebellum was presented. We discuss the unique treatment challenges of anti-NMDAR. NORSE and generalized nonconvulsive status epilepticus.

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Related Papers

Journal of the Neurological Sciences
Rahul Rathakrishnan, Einar P Wilder-Smith
Revista de neurologia
N Torres-CanoJ Moliner-Ibanez
Neurología : publicación oficial de la Sociedad Española de Neurología
J García-UllA G Masegosa
© 2022 Meta ULC. All rights reserved